help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hu, J.-M.
Right arrow Articles by Munck, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hu, J.-M.
Right arrow Articles by Munck, A.
Molecular Endocrinology 11 (3): 305-311
Copyright © 1997 by The Endocrine Society

Control by Basal Phosphorylation of Cell Cycle-Dependent, Hormone-Induced Glucocorticoid Receptor Hyperphosphorylation

Jiong-Ming Hu, Jack E. Bodwell and Allan Munck

Department of Physiology Dartmouth Medical School Lebanon, New Hampshire 03756-0001

Mouse glucocorticoid receptors (GRs) are phosphorylated in the N-terminal domain at serine/threonine residues, most lying in consensus sequences for cell cycle-associated kinases. Glucocorticoid agonists, but not antagonists, induce hyperphosphorylation. Phosphorylation of GRs overexpressed in Chinese hamster ovary (CHO) cells is cell cycle-dependent: basal phosphorylation in S phase is one third that in G2/M; glucocorticoids induce hyperphosphorylation in S but not G2/M, paralleling the reported sensitivity in S and resistance in G2/M of proliferating cells to transcriptional activation by glucocorticoids. This parallel led us to investigate what controls hyperphosphorylation. We tested three hypotheses: hyperphosphorylation is controlled by 1) negative charge due to basal GR phosphorylation, being permitted in S by low charge and blocked in G2/M by high charge; 2) presence in S and absence in G2/M of required kinases; 3) availability in S and lack in G2/M of unoccupied phosphorylatable sites. Our results are inconsistent with 2) and 3), but strongly support 1). GR mutants with alanines (A7GR) or glutamates (E7GR) replacing all but one phosphorylated site were overexpressed in CHO cells. Serine 122 remained intact to report GR phosphorylation. Consistent with hypothesis 1, with A7GRs hormone-induced hyperphosphorylation occurred in both S and G2/M (thus revealing kinase activity for hyperphosphorylation of at least serine 122 in both phases), whereas with E7GRs it occurred in neither phase. We conclude that basal GR phosphorylation controls hormone-induced GR hyperphosphorylation by modulating negative charge in the N-terminal domain and could potentially control other cell cycle-dependent GR properties.




This article has been cited by other articles:


Home page
Toxicol SciHome page
J. C. Davey, J. E. Bodwell, J. A. Gosse, and J. W. Hamilton
Arsenic as an Endocrine Disruptor: Effects of Arsenic on Estrogen Receptor-Mediated Gene Expression In Vivo and in Cell Culture
Toxicol. Sci., July 1, 2007; 98(1): 75 - 86.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
O. S. Usmani, K. Ito, K. Maneechotesuwan, M. Ito, M. Johnson, P. J. Barnes, and I. M. Adcock
Glucocorticoid Receptor Nuclear Translocation in Airway Cells after Inhaled Combination Therapy
Am. J. Respir. Crit. Care Med., September 15, 2005; 172(6): 704 - 712.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
K. De Bosscher, W. Vanden Berghe, and G. Haegeman
The Interplay between the Glucocorticoid Receptor and Nuclear Factor-{kappa}B or Activator Protein-1: Molecular Mechanisms for Gene Repression
Endocr. Rev., August 1, 2003; 24(4): 488 - 522.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
G. A. Abel, G. M. Wochnik, J. Ruegg, A. Rouyer, F. Holsboer, and T. Rein
Activity of the GR in G2 and Mitosis
Mol. Endocrinol., June 1, 2002; 16(6): 1352 - 1366.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. G. Dobson, C. P. F. Redfern, N. Unwin, and J. U. Weaver
The N363S Polymorphism of the Glucocorticoid Receptor: Potential Contribution to Central Obesity in Men and Lack of Association with Other Risk Factors for Coronary Heart Disease and Diabetes Mellitus
J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 2270 - 2274.
[Abstract] [Full Text]


Home page
Mol. Cell. Biol.Home page
B. G. Rowan, N. Garrison, N. L. Weigel, and B. W. O'Malley
8-Bromo-Cyclic AMP Induces Phosphorylation of Two Sites in SRC-1 That Facilitate Ligand-Independent Activation of the Chicken Progesterone Receptor and Are Critical for Functional Cooperation between SRC-1 and CREB Binding Protein
Mol. Cell. Biol., December 1, 2000; 20(23): 8720 - 8730.
[Abstract] [Full Text]


Home page
Mol. Endocrinol.Home page
J. Richardson, C. Vinson, and J. Bodwell
Cyclic Adenosine-3',5'-Monophosphate-Mediated Activation of a Glutamine Synthetase Composite Glucocorticoid Response Element
Mol. Endocrinol., April 1, 1999; 13(4): 546 - 554.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
R. J. G. Hache, R. Tse, T. Reich, J. G. A. Savory, and Y. A. Lefebvre
Nucleocytoplasmic Trafficking of Steroid-free Glucocorticoid Receptor
J. Biol. Chem., January 15, 1999; 274(3): 1432 - 1439.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1997 by The Endocrine Society